FDA Orange Book · active-ingredient family
Dasiglucagon hydrochloride
Dasiglucagon hydrochloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ZEGALOGUE · NDA 214231
1
Brand (NDA)
0
Generics (ANDA)
2
Listed patents
2
Exclusivity periods
Brand (NDA) products · solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ZEGALOGUERLD×2 | ZEALAND PHARMA | NDA 214231 | — | Mar 22, 2021 |
Marketing exclusivity (2)
- NCENew chemical entity exclusivity (5 years)
Mar 22, 2026
3 mo ago
- NCENew chemical entity exclusivity (5 years)
Mar 22, 2026
3 mo ago
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11795204 | Jan 06, 2034 | in 7 yr 8 mo | U-3752 |
| 10442847 | Mar 22, 2035 | in 8 yr 11 mo | SubstanceProduct |
Dasiglucagon hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

